🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Iress 
Financial services / Financial Services and Technology
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebThe risks related to Iressa, also known as gefitinib, include the following:
1. Development of interstitial lung disease (ILD). ILD is a rare but serious form of lung injury. It can cause coughing, breathing difficulties, and even death.
2. Severe skin reactions. Iressa can increase your risk of severe skin reactions, including rashes, blisters, and peeling skin.
3. Liver damage. Iressa can cause liver damage, which may lead to jaundice and other symptoms.
4. Eye problems. Iressa can cause vision changes, including blurred vision, or it may even cause eye problems such as swelling of the macula, which may lead to vision loss.
5. Low white blood cell count. Iressa can cause a type of side effect called leukopenia, which can decrease your body’s ability to fight infection.
6. Allergic reactions. Allergic reactions to Iressa are rare, but they can occur. Symptoms of an allergic reaction include hives, facial swelling, difficulty breathing, and chest tightness.
Wait! There's more — sign up for free or log in